Genito-Urinary Drugs Market Global Report 2017

The genitourinary drugs market covers drugs that are used in the treatment of diseases such as urinary tract infections, male reproductive diseases, voiding diseases, female reproductive diseases, glomerular disorders, urinary calculi, cystic kidney disease, Reno vascular diseases, benign prostate diseases, and other related diseases.

Some of the major drugs in the market include Avastin, Trimethoprim/sulfamethoxazole, Fosfomycin, Nitrofurantoin, Ciprofloxacin, Sildinafil, Levofloxacin, Cephalexin, Ceftriaxone, and Azithromycin.

The global genito-urinary drugs market was estimated to be around $60 billion as of 2016. The genito-urinary drugs market made up around 5.5% of the overall pharmaceuticals market in 2016. The genito-urinary drugs market was the nineth largest market in the global pharmaceutical market in 2016.

New Of Combination Products
Launch of combination products for the treatment of urinary tract infections is an emerging trend in the genitourinary disorders drugs market. Competitors are developing combination drugs to fight multi-drug resistant bacteria and also expanding indications for existing drugs for the treatment of genitourinary disorder drugs. For instance, Merck Sharp & Dohme Corp. offers ZERBAXA, a combination drug of a novel cephalosporin and a beta-lactamase inhibitor used for the treatment of complicated urinary tract infections.

1. Genito-Urinary Drugs Market Characteristics;

2. Genito-Urinary Drugs Market Size And Growth;
2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

3. Pestle Analysis;
3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

4. Genito-Urinary Drugs Market Customer Information;

5. Genito-Urinary Drugs Market Segmentation;
5.1. Global Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; 5.2. Global Genito-Urinary Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Genito-Urinary Drugs Market Trends And Strategies;

6. Genito-Urinary Drugs Market Regional And Country Analysis;
6.1. Global Genito-Urinary Drugs Market, 2016, By Region; 6.2. Global Genito-Urinary Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Genito-Urinary Drugs Market, 2016, By Country; 6.4. Genito-Urinary Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;

7. Global Genito-Urinary Drugs Market Comparison With Macro Economic Factors;
7.1. Genito-Urinary Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Genito-Urinary Drugs Expenditure, Global;

8. Genito-Urinary Drugs Market Comparison With Macro Economic Factors Across Countries;
8.1. Genito-Urinary Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Genito-Urinary Drugs Expenditure, By Country;

9. Genito-Urinary Drugs Market Comparison With Industry Metrics;
9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Genito-Urinary Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Genito-Urinary Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Genito-Urinary Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Contraceptives, 2015, By Country; 9.10. Global Number Of Obstetricians And Gynaecologists 2016, By Country; 9.11. Global Genito-Urinary Drugs Market Revenue Versus Number Of Obstetricians And Gynaecologists, 2016, By Country; 9.12. Global Number Of General Practitioners 2016, By Country; 9.13. Global Genito-Urinary Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;

10. Asia-Pacific Genito-Urinary Drugs Market;
10.1.1. Asia-Pacific Genito-Urinary Drugs Market Overview; 10.1.2. Asia-Pacific Genito-Urinary Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Genito-Urinary Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.2. Asia-Pacific Genito-Urinary Drugs Market: Country Analysis; 10.3. China Genito-Urinary Drugs Market; 10.3.1. China Genito-Urinary Drugs Market Overview; 10.3.2. China Genito-Urinary Drugs Historic Market, 2012 - 2016; 10.3.3. China Genito-Urinary Drugs Forecast Market, 2016 - 2020; 10.3.4. China Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.3.5. China Genito-Urinary Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Genito-Urinary Drugs Expenditure, 2012 - 2020; 10.4. India Genito-Urinary Drugs Market; 10.4.1. India Genito-Urinary Drugs Market Overview; 10.4.2. India Genito-Urinary Drugs Historic Market, 2012 - 2016; 10.4.3. India Genito-Urinary Drugs Forecast Market, 2016 - 2020; 10.4.4. India Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.4.5. India Genito-Urinary Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Genito-Urinary Drugs Expenditure, 2012 - 2020; 10.5. Japan Genito-Urinary Drugs Market; 10.5.1. Japan Genito-Urinary Drugs Market Overview; 10.5.2. Japan Genito-Urinary Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Genito-Urinary Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.5.5. Japan Genito-Urinary Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Genito-Urinary Drugs Expenditure, 2012 - 2020; 10.6. Australia Genito-Urinary Drugs Market; 10.6.1. Australia Genito-Urinary Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Genito-Urinary Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 10.6.4. Australia Genito-Urinary Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Genito-Urinary Drugs Expenditure, 2012 - 2020;

11. Western Europe Genito-Urinary Drugs Market;
11.1.1. Western Europe Genito-Urinary Drugs Market Overview; 11.1.2. Western Europe Genito-Urinary Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Genito-Urinary Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.2. Western Europe Genito-Urinary Drugs Market: Country Analysis; 11.3. UK Genito-Urinary Drugs Market; 11.3.1. UK Genito-Urinary Drugs Market Overview; 11.3.2. UK Genito-Urinary Drugs Historic Market, 2012 - 2016; 11.3.3. UK Genito-Urinary Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.3.5. UK Genito-Urinary Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Genito-Urinary Drugs Expenditure, 2012 - 2020; 11.4. Germany Genito-Urinary Drugs Market; 11.4.1. Germany Genito-Urinary Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Genito-Urinary Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.4.4 Germany Genito-Urinary Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Genito-Urinary Drugs Expenditure, 2012 - 2020; 11.5 France Genito-Urinary Drugs Market; 11.5.1 France Genito-Urinary Drugs Historic Market, 2012 - 2016; 11.5.2 France Genito-Urinary Drugs Forecast Market, 2016 - 2020; 11.5.3 France Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.5.4 France Genito-Urinary Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Genito-Urinary Drugs Expenditure, 2012 - 2020; 11.6. Italy Genito-Urinary Drugs Market; 11.6.1. Italy Genito-Urinary Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Genito-Urinary Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;; 11.6.4. Italy Genito-Urinary Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Genito-Urinary Drugs Expenditure, 2012 - 2020; 11.7. Spain Genito-Urinary Drugs Market; 11.7.1. Spain Genito-Urinary Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Genito-Urinary Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; 11.7.4. Spain Genito-Urinary Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Genito-Urinary Drugs Expenditure, 2012 - 2020;


12. Eastern Europe Genito-Urinary Drugs Market;
12.1.1. Eastern Europe Genito-Urinary Drugs Market Overview; 12.1.2. Eastern Europe Genito-Urinary Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Genito-Urinary Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 12.2. Eastern Europe Genito-Urinary Drugs Market: Country Analysis; 12.3. Russia Genito-Urinary Drugs Market; 12.3.1. Russia Genito-Urinary Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Genito-Urinary Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 12.3.4. Russia Genito-Urinary Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Genito-Urinary Drugs Expenditure, 2012 - 2020;

13. North America Genito-Urinary Drugs Market;
13.1.1. North America Genito-Urinary Drugs Market Overview; 13.1.2. North America Genito-Urinary Drugs Historic Market, 2012 - 2016; 13.1.3. North America Genito-Urinary Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; 13.2. North America Genito-Urinary Drugs Market: Country Analysis; 13.3. USA Genito-Urinary Drugs Market; 13.3.1. USA Genito-Urinary Drugs Historic Market, 2012 - 2016; 13.3.2. USA Genito-Urinary Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 13.3.4. USA Genito-Urinary Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Genito-Urinary Drugs Expenditure, 2012 - 2020;


14. South America Genito-Urinary Drugs Market;
14.1.1. South America Genito-Urinary Drugs Market Overview; 14.1.2. South America Genito-Urinary Drugs Historic Market, 2012 - 2016; 14.1.3. South America Genito-Urinary Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 14.2. South America Genito-Urinary Drugs Market: Country Analysis; 14.3. Brazil Genito-Urinary Drugs Market; 14.3.1. Brazil Genito-Urinary Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Genito-Urinary Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ; 14.3.4. Brazil Genito-Urinary Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Genito-Urinary Drugs Expenditure, 2012 - 2020;

15. Middle East Genito-Urinary Drugs Market;
15.1.1. Middle East Genito-Urinary Drugs Market Overview; 15.1.1. Middle East Genito-Urinary Drugs Market Overview; 15.1.2. Middle East Genito-Urinary Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Genito-Urinary Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics; ;

16. Africa Genito-Urinary Drugs Market;
16.1.1. Africa Genito-Urinary Drugs Market Overview; 16.1.2. Africa Genito-Urinary Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Genito-Urinary Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Genito-Urinary Drugs Market, 2016, By Segment; Hormonal Contraceptives; Drugs For Benign Prostatic Hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Harmonal Replacement Therapy; Diuretics;

17. Genito-Urinary Drugs Market Competitive Landscape;
17.1. Company Profiles; 17.2. Pfizer Inc.; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Bristol-Myers Squibb Company; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Abbott Laboratories; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.3. Strategy; 17.5.4. Financial Performance; 17.6. Bayer Ag; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

18. Key Mergers And Acquisitions In The Genito-Urinary Drugs Market;

19. Market Background: Pharmaceutical Drugs Market;
19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;

20. Pharmaceuticals Industry Financial Margins;

21. Appendix;
21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer